News

Under the agreement, Ascletis gained an exclusive license from Alnylam to develop and commercialise ALN-VSP in China including Hong Kong, Macau and Taiwan, while Alnylam retains all rights

Relday is based on a combination of its DosePro needle-free, subcutaneous drug delivery system with a proprietary, subcutaneous once-monthly formulation of risperidone for treating schizophrenia. The company expects

Omontys (peginesatide) injection is a synthetic, pegylated, peptide-based erythropoiesis-stimulating agent (ESA) indicated to treat anemia in patients with chronic kidney disease (CKD). According to the agreement, which ends

The GS Xceed system was shown to reduce cell line development timelines by up to six weeks over the existing CHOK1SV based system and has achieved titers of

The starting point for the development of proprietary analogs in the collaboration is VS-507, a proprietary formulation of salinomycin. Verastem’s Wnt signaling and cancer stem cell assays will

Emerson accomplished installation of its PlantWeb digital plant architecture at the three plants, including DeltaV digital automation systems, Rosemount measurement instruments, and AMS Suite predictive maintenance software. Jubilant

Ranbaxy wants to go ahead with its expansion plans though American regulators blocked imports of company’s 31 medicines over quality issues. The company is also considering to start

The company has incorporated the Affymetrix GCS3000, Sequenom MassArray, and LifeTech Ion Torrent technologies to recognise polymorphisms involved in drug response and adverse drug events as well as

As part of the acquisition, Merus Labs will manufacture, market, and sell darifenacin, used to treat overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. The